本页面由Tiger Trade Technology Pte. Ltd.提供服务

IN8bio, Inc.

1.19
+0.01501.28%
盘后1.190.00000.00%18:19 EDT
成交量:3,345
成交额:3,957.73
市值:1,166.88万
市盈率:-0.63
高:1.20
开:1.17
低:1.17
收:1.17
52周最高:2.73
52周最低:0.8800
股本:984.71万
流通股本:850.41万
量比:0.05
换手率:0.04%
股息:- -
股息率:- -
每股收益(TTM):-1.8935
每股收益(LYR):-4.4441
净资产收益率:-111.11%
总资产收益率:-58.37%
市净率:0.64
市盈率(LYR):-0.27

数据加载中...

2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

SEC问询函

Form CORRESP - Correspondence
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/05/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/03/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/13

重要事件披露

Form 8-K - Current report
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/09

重要事件披露

Form 8-K - Current report
2026/01/26

SEC问询函

Form CORRESP - Correspondence
2025/12/19

重要事件披露

Form 8-K - Current report